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ABSTRACT 
In this work, a multi-class method for the simultaneous determination of 17 emerging 
contaminants, including pharmaceuticals and personal care products, has been developed. 
Target analytes were two anti-inflammatories, a lipid regulator agent, two angiotensin II 
antagonists, two antiepileptic drugs and a diuretic. Among personal care products, four 
preservatives and five UV filters were included. The method is based on solid-phase extraction 
(SPE) using Oasis HLB cartridges followed by ultra-high performance liquid chromatography–
tandem mass spectrometry (UHPLC–MS/MS). Up to three simultaneous transitions per 
compound were acquired to assure a reliable identification. A detailed study of the extraction 
process efficiency and matrix effects was carried out in surface water and effluent wastewater. 
The use of isotope-labeled internal standards (ILIS) was tested to compensate both potential 
SPE losses during sample extraction and signal suppression/enhancement observed, especially 
in EWW. Satisfactory correction in all water samples was only ensured when the own analyte 
ILIS was used. The use of analogues ILIS was a rather useful approach for correction in the 
majority of the samples tested when analyte ILIS was unavailable. The method was 
successfully validated in five different surface water (SW) samples and five effluent wastewater 
(EWW) samples spiked at two concentration levels (0.05 and 0.5 μg/L in SW; 0.1 and 0.5 μg/L 
in EWW). The developed method was applied to the analysis of 22 samples (SW and EWW) 
from the Spanish Mediterranean area and 51 reservoir water samples from Colombia. Personal 
care products were frequently detected, with the highest concentrations corresponding to 
benzophenone and benzophenone-4 (samples from Spain), and methylparaben (samples from 
Colombia). Several pharmaceuticals were detected in the Spanish samples, where irbesartan 
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and valsartan – two Angiotensin II antagonists that are not commonly monitored in the aquatic 
environment – were the compounds most frequently detected. 
Keywords 
Pharmaceuticals; Personal care products; Ultra-high performance liquid 
chromatography; Tandem mass spectrometry; Matrix effects; Surface water and wastewater. 
 
 
1. Introduction 
Pharmaceuticals and personal care products (PPCPs) are a diverse group of chemicals 
that include human and veterinary drugs, food supplements and other chemicals used in 
cosmetics, fragrances and sun-screen agents [1]. They have become the focus of global 
environmental researchers’ attention over the last decade [2] due to their extensive human and 
veterinary consumption and their potential negative impact on the environment, living organisms 
and human health. PPCPs are suspected to cause elevated rates of cancer, reproductive 
impairment in humans and other animals and development and spread of antimicrobial 
resistance [2-4]. Recent studies reported that these contaminants do not need to be persistent 
in the environment to cause negative effects due to their continuous release [1, 5, 6]. They have 
been detected in different natural water systems that include rivers, lakes and reservoirs [7-9]. 
PPCPs enter into the aquatic environment mainly through effluents of wastewater 
treatment plants (WWTPs) [6]. A few compounds are transformed or retained in the sludge by 
conventional water treatment processes. However, most of compounds are persistent and 
polar, and survive the passage through WWTPs, being released via effluents into receiving 
aquatic environments [1-3]. 
Pharmaceuticals have been extensively studied in the last years due to their large 
consumption and environmental implications. However, until recently, less interest has been 
paid to the presence of personal care products (PCPs) in environmental waters [10]. PCPs 
include UV-filters, preservatives, antimicrobials, musk fragrances, insect repellents and, in 
general, ingredients or excipients used in cosmetics, food supplements, shampoos, 
toothpastes, sun screens agents, antiseptics and personal care products formulations and 
manufacture [1, 10]. Among them, UV filters and preservatives are considered of higher 
relevance. UV filters are used as ingredients in some sunscreens and a wide variety of 
cosmetics (skin and hair care products, lotions, creams, fragrances) [11-13]. These compounds 
enter the aquatic environment either directly via wash-off from skin and cloth during recreational 
activities, or indirectly via wastewater or swimming pool waters [11]. The most commonly UV 
filters are benzophenones. Two of them, benzophenone-3 and benzophenone-4 are included in 
the list of compounds that can be employed as UV filters in sunscreen cosmetic products 
according to the European Union Legislation [14]. Benzophenone, benzophenone-1 and 
benzophenone-2 seem to present hormonal activity [11-12]. Moreover, benzophenone has been 
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listed among chemicals suspected of having endocrine disrupting effects [12]. These 
compounds are characterised by the presence of aromatic rings, often with attached 
hydrophobic groups. They are lipophilic and can therefore be accumulated in the human body 
and the environment [15]. 
Among the group of preservatives, parabens are the most commonly used. These are 
esters of p-hydroxybenzoic acid and are suspected to be endocrine disruptors [10, 16] 
Parabens are widely used, due to their anti-bactericidal and anti-fungicidal properties, in 
cosmetic products and pharmaceuticals, and in food and beverage processing [16-18]. 
Advanced analytical methodology is needed in order to study the occurrence and 
distribution of PPCPs in the environment. Most of recent methods are based on liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) using triple quadrupole (QqQ) 
analyzer [10], which has become the technique of choice in this field due to its high selectivity 
and sensitivity [2]. However, one of the major drawbacks associated to LC-MS/MS methods is 
matrix effect, which results in suppression or enhancement of the analyte signal due to the 
presence of co-extracted matrix components that affect analyte ionization. These undesirable 
effects can hamper the identification, and drastically affect the quantification of analytes, 
especially when dealing with complex matrices [19]. 
The goal of this paper is to develop rapid, accurate and sensitive analytical 
methodology based on UHPLC–MS/MS for the simultaneous determination (quantification and 
confirmation) of PPCPs in surface and wastewater. A notable number of PPCPs (17 
compounds) has been included in the method scope in order to have wider and more realistic 
knowledge on the presence of these compounds in the environment. The main benzophenones, 
including those listed in the EU legislation, and the parabens most extensively used in 
cosmetics and food processing, methyl-, ethyl- and buthyl-paraben [10] have been included in 
the target list of analytes. Several ILIS have been tested for correction of matrix effects and/or 
potential losses associated to the SPE step. The method was applied to the analysis of 73 
samples (surface water, effluent wastewater and reservoir water) collected at different sites in 
Spain and Colombia. Although emerging contaminants are still unregulated in water, their 
presence is a matter of concern, mainly in those cases where treated water is used for drinking 
water supply. This occurs in Colombia, where artificial reservoirs are frequently used to this aim. 
Reservoirs are supplied with water from rivers or tributaries, which receive urban and 
agricultural wastewater discharges. For this reason, it is important to monitor water quality in 
Colombia’s reservoirs, specifically for those PPCPs used in human applications and 
households. The presence and distribution of PPCPs in Colombia have not been reported, and 
to the best of our knowledge, this is the first study reporting data on PPCPs in this country. The 
methodology developed in this work will be implemented in the laboratory of GDCON group 
from Antioquia University (Colombia) since 2012. 
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2. Experimental 
2.1. Reagents and chemicals 
Reference standards were purchased from Sigma-Aldrich (St Louis, MO, USA), LGC 
Promochem (London, UK), Dr. Ehrenstorfer (Augsburg, Germany) and Toronto Research 
Chemicals (Ontario, Canada). Their chemical structure is shown in Fig. 1. 
Isotopically labeled compounds diclofenac-d4, ibuprofen-d3, valsartan-d8, ethylparaben-
d4 and benzophenone-3-d5, were from CDN Isotopes (Quebec, Canada). 
HPLC-grade methanol (MeOH) and HPLC-grade acetonitrile (ACN) were purchased 
from Scharlab (Barcelona, Spain). HPLC-grade water was obtained from distilled water passed 
through a Milli-Q water purification system (Millipore, Bedford, MA, USA). Formic acid (HCOOH, 
content >98%), ammonium acetate (NH4Ac, reagent grade) and ammonia (NH3, solution 32%, 
reagent grade) were supplied by Scharlab (Barcelona, Spain). 
Individual stock solutions of PPCPs were prepared dissolving 25 mg, accurately 
weighted, in 50 mL methanol, obtaining a final concentration of 500 mg/L. Intermediate 
solutions were prepared in methanol, and were used to prepare a mix of all compounds at 500 
μg/L in methanol–water (40:60, v/v). This mix solution was subsequently diluted with HPLC-
grade water to prepare working solutions. 
Individual stock solutions of ILIS were prepared in methanol. A mix working solution at 
250 μg/L was prepared in water and used as surrogate. 
All standard solutions were stored in amber glass bottles. Stock solutions were stored at 
−20 °C, and intermediate and working solutions at 4 °C. 
Cartridges used for SPE were Oasis HLB (60 mg) and Oasis MCX (150 mg) from 
Waters (Milford, MA, USA). 
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Compound Structure Compound Structure
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Fig. 1. Structures and molecular formula of the selected compounds. 
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2.2. Liquid chromatography 
UHPLC analysis were carried out using an Acquity UPLC system (Waters Corp., 
Milford, MA, USA), equipped with a binary solvent manager and a sample manager. 
Chromatographic separation was performed using an Acquity UPLC BEH C18 column, 1.7 μm, 
50 mm×2.1 mm (i.d.) (Waters) at a flow rate of 0.3 mL/min. The column was kept at 40 °C and 
the sample manager was maintained at 5 °C. Mobile phase consisted of a water 0.01% 
HCOOH/methanol gradient. The methanol percentage was changed linearly as follows: 0 min, 
10%; 9 min, 90%; 10 min, 90%; 10.1 min; 10%. Analysis run time was 12 min. The sample 
injection volume was 20 μL. 
 
2.3. Mass spectrometry  
A TQD (triple quadrupole) mass spectrometer with an orthogonal Z-spray-electrospray 
(ESI) was used (Waters Corp., Milford, MA, USA). Drying gas as well as nebulising gas was 
nitrogen generated from pressurized air in a N2 LC–MS (Claind, Teknokroma, Barcelona, 
Spain). The cone gas and the desolvation gas flows were set at 60 and 1200 L/h, respectively. 
For operation in MS/MS mode, collision gas was Argon 99.995% (Praxair, Valencia, Spain) at 
2×10
−3
 mbar in the T-Wave collision cell. Capillary voltages of −3.0 kV (negative ionization 
mode) and 3.5 kV (positive ionization mode) were applied. The interface temperature was set to 
500 °C and the source temperature to 120 °C. A dwell time of 0.01 s was selected. 
Masslynx 4.1 (Micromass, Manchester, UK) software was used to process quantitative 
data. 
 
2.4. Recommended procedure 
Water samples were centrifuged at 4500 rpm for 5 min, when suspended particulate 
matter was observed. 100 mL water sample were taken and 100 μL of the ILIS mix working 
solution were added to give a final concentration for each ILIS of 0.25 μg/L. Oasis HLB 
cartridges were conditioned with 3 mL MeOH and 3 mL HPLC-grade water before use. Then, 
the samples were loaded onto the cartridge and, after drying under vacuum, analytes were 
eluted with 5 mL methanol. The extract was evaporated to dryness under a gentle nitrogen 
stream at 40 °C and reconstituted with 1 mL MeOH–water (10:90, v/v). Finally, 20 μL were 
injected in the UHPLC–MS/MS system under the conditions shown in Table 1. Quantification 
was made with calibration standards prepared in solvent, using relative responses analyte/ILIS, 
or absolute responses, depending on whether ILIS was used for correction or not. ILIS were 
used to correct for matrix effects and/or SPE potential errors as shown in Tables 2 and 3. 
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2.5. Validation study 
The linearity of the method was studied by analyzing standard solutions (in triplicate) at 
seven concentrations in the range from 1 to 100 μg/L (equivalent to 0.01–1 μg/L in the water 
sample). Satisfactory linearity using least squares regression was assumed when the 
correlation coefficient (r) was higher than 0.99 and residuals lower than 30% without significant 
trend, based on relative responses (analyte peak area/ILIS peak area), except for those 
compounds that were quantified without ILIS (absolute response). 
Accuracy (expressed as percentage recovery) and precision (expressed in terms of 
relative standard deviation (RSD)) were studied by means of recovery experiments in several 
surface water (SW) and effluent wastewater (EWW) spiked at two concentrations (0.05 in 0.5 
μg/L in SW; 0.1 and 0.5 μg/L in EWW). The method was validated in five SW samples collected 
in different sites of the Mediterranean Spanish area of Valencia (Mijares and Jucar rivers, and 
Albufera de Valencia, Clot de Burriana, and Tavernes de la Valldigna lakes) and five 24-h 
composite EWW samples collected from the Castellón de la Plana WWTP along five 
consecutive days. For each individual sample, recovery experiments were performed in 
duplicate, giving a total number of 10 data for SW and 10 for EWW at each spiked 
concentration. 
The limit of quantification (LOQ) was estimated for a signal-to-noise (S/N) ratio 10 from 
the sample chromatograms at the lowest validation level tested, using the quantification 
transition. True blank samples were not found for several analytes, which were present in the 
samples tested. In these cases, LOQ values were estimated from the analyte levels quantified 
in the non-spiked “blanks”. The instrumental limit of detection (LOD) was estimated for S/N=3 
from the chromatograms of standards at the lowest concentration level. 
 
2.6. Application to water samples 
The method was applied to 73 samples (surface water, effluent wastewater and 
reservoir water) collected at different sites in Spain and Colombia. 
Eleven SW samples were collected at selected sites from the Spanish Mediterranean 
area of Valencia. Another eleven EWW were also collected, consisting on 24-h composite urban 
wastewater samples, from different WWTPs of the same area. All samples were stored in the 
dark at −18 °C in polyethylene high-density bottles until analysis. 
Fifty-one reservoir water samples were collected from two reservoirs situated in the 
department of Antioquia (Colombia) that are used for drinking water supply. In total, eleven 
sampling locations were selected for reservoir 1 (located in the east of Antioquia), and 10 for 
reservoir 2 (in the north of Antioquia) and collected at three depths in the water column: 
subsurface, photic zone limit and reservoir bottom. Due to the low depth, it was only possible to 
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take samples at the surface and at the bottom in some stations. Samples were collected in July 
and August 2011 using a Schindler bottle. Then, 100 mL of each sample were transferred to a 
polyethylene bottle. A total of 51 samples were collected and transported to the laboratory 
under cooled conditions (4 °C). Upon reception in the Colombian laboratory, samples were 
immediately processed (SPE) and the cartridges were sent to Spain for LC–MS/MS analysis. 
No stability test of analytes on the SPE cartridges was made. 
 
3. Results and discussion 
In this work, 17 pharmaceuticals and personal care products (PPCPs) were studied. 
Pharmaceuticals selected belong to different therapeutical groups: anti-inflammatories, 
antiepileptic drugs, lipid regulators, angiotensin II antagonists and diuretics. The choice of 
diclofenac, ibuprofen and clofibric acid was based on their high usage in both Spain and 
Colombia [20]. Valsartan, irbesartan, gabapentin, carbamazepine and furosemide have been 
frequently detected in wastewater of the Valencian area [21]. The remaining nine compounds 
were personal care products (UV filters and preservatives). They were selected due to their 
wide use and to their potential harmful effects on human and aquatic organisms [10, 22]. 
 
3.1. MS and MS/MS optimization  
Full-scan and MS/MS mass spectra of analytes were obtained from infusion of 1 mg/L 
methanol/water (50:50, v/v) individual standard solutions at a flow rate of 10 μL/min. For those 
compounds that showed abundant sodium adduct [M+Na]
+
 (e.g. carbamazepine), the addition 
of HCOOH into the infusion vial favored the [M+H]
+
 formation. NH4Ac was also added into the 
infusion vial in order to evaluate the possible presence of ammonium adducts, or to minimize 
the [M+Na]
+
 formation. Although sodium adducts decreased in presence of ammonium, the 
abundance of the protonated molecules was lower than using formic acid. Therefore, formic 
acid was selected as additive. 
Valsartan, irbesartan, benzophenone-1, benzophenone-2 and benzophenone-3 were 
ionized in both positive and negative modes. With the exception of benzophenone-2, positive 
ionization mode was selected because of the better sensitivity reached under this mode. The 
most abundant ion was [M+H]
+
, or [M–H]
−
, and it was selected as precursor ion. The presence 
of halogenated atoms (Cl) in some compounds (diclofenac and clofibric acid) allowed using two 
different precursor ions (corresponding to 
35
Cl and 
37
Cl, respectively). 
Three SRM transitions were selected for each compound to assure the reliable 
confirmation of the compound detected. The most abundant product ion was used for 
quantification (Q) whereas the second and the third most sensitive transitions were used for 
confirmation (q1 and q2). For ibuprofen, diclofenac, irbesartan, parabens and some 
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benzophenones, only one (ibuprofen) or two transitions (the rest of compounds) could be 
monitored due to their poor fragmentation. For example, for parabens the m/z=92 product ion, 
corresponding to [C6H4O]
−
, was selected. This ion was the most abundant fragment for 
methylparaben, ethylparaben and propylparaben, and therefore it was selected for 
quantification, while for butylparaben it was selected for confirmation. For this compound, [M–
H–CH2CH2CH2CH3]
−
, corresponding to the lost of a butyl radical, was the most abundant ion 
[22, 23]. 
For benzophenone-1 and benzophenone-3, similar fragment ions were obtained due to 
their analogous chemical structure. In both cases, the loss of the benzene group [M+H-C6H6]
+
 
corresponded to the main product ion (selected for quantification), while [C7H5O]
+
 was selected 
for confirmation, as previously reported [24]. 
Regarding ILIS, only one transition was required. In the case of diclofenac-d4, the 
transition 300.1>256.1 was chosen in order to avoid the overlap between the natural analyte 
(isotope peak due to the presence of two chlorine atoms; 2Cl
37
) and the ILIS signal (d4), which 
would have occurred if the transition 298.1>254.1 had been chosen. In order to obtain enough 
points to define the chromatographic peak, the SRM transitions were distributed along six 
overlapping windows using dwell times of 10 ms. This favorable overlapping between positive 
and negative time windows was possible due to the low positive-to-negative-switching time 
(20 ms) attainable by the triple quadrupole analyzer used in this work. 
Mass spectrometry parameters, precursor and product ions selected, instrumental 
LODs and ion ratios (Q/q) used for confirmation are shown in Table 1. 
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3.2. Chromatographic conditions 
In this work, a UPLC BEH C18 column (50 mm × 2.1 mm, 1.7 μm) was chosen. To 
optimize the chromatographic separation, methanol and acetonitrile were evaluated as mobile 
phase organic solvents, and HCOOH at various concentrations was tested. Acetonitrile was 
discarded because sensitivity got worse for parabens and for most compounds ionized under 
positive mode. 
The use of solvents without any additive provided better sensitivity for most target 
compounds. However, poor peak shape was observed for several compounds (e.g. valsartan, 
benzophenone-2), which was improved when adding HCOOH. 
The addition of HCOOH improved the chromatographic separation of several 
compounds determined in positive mode. The presence of acid also favored the 
chromatographic retention of acidic compounds, especially for diclofenac and clofibric acid, 
determined in negative mode. Finally, 0.01% HCOOH as the aqueous phase, and MeOH as 
organic phase, were selected as a compromise for the simultaneous chromatographic 
separation of both positive and negative ionized analytes. 
 
3.3. Solid-phase extraction (SPE) study 
Two cartridges with different retention mechanisms were compared in this work: the 
hydrophilic–lipophilic balanced Oasis HLB and the mixed polymeric-cation exchange sorbent 
Oasis MCX. Oasis HLB was tested at natural sample pH, while MCX cartridges required 
acidification of the water sample before loading in order to retain the protonated basic 
compounds under these conditions. 
The SPE process efficiency for the selected compounds in both cartridges was tested in 
SW and EWW matrices. It was estimated as recovery percentage (RE). 
For this purpose, the quotient between the responses obtained for samples spiked (0.5 
μg/L) before SPE and for sample extracts spiked (50 μg/L) after SPE were compared [25]. This 
experiment was made in duplicate. 
“Blank” samples, spiked only with the ILIS mix, were also processed to subtract the 
responses of possible target compounds that were normally present in the water samples. 
The recoveries of the SPE process in both cartridges are depicted in Fig. 2 for a SW 
sample (Mijares river). Similar pattern was observed in EWW, although with slightly lower 
recoveries, surely due to the presence of matrix interferents, more abundant in wastewater than 
in surface water, resulting in a reduction of the sorption efficiency of cartridges. 
13 
 
In the case of Oasis HLB, satisfactory RE were obtained for all compounds except for 
gabapentin, benzophenone and benzophenone-3, which suffered some losses in the SPE 
process, especially significant for gabapentin. This analyte is small, highly polar molecule, with 
acidic and basic groups, and it is poorly retained on Oasis HLB. On the contrary, gabapentin 
was efficiently retained on Oasis MCX due to protonation of the free basic amino group, yielding 
higher recovery (up to 90%). In general, quantitative recoveries were observed for the majority 
of PPCPs in both cartridges, except for several parabens and benzophenones, which 
recoveries decreased considerably with MCX. As better recoveries for a higher number of 
compounds were achieved with Oasis HLB, these cartridges were selected for method 
development and validation purposes. 
 
Fig. 2. Recoveries of the SPE process (RE) with Oasis HLB and Oasis MCX cartridges in SW 
sample. 
 
The lower SPE efficiency for benzophenone could be corrected by the use of 
benzophenone-3-d5, used as surrogate ILIS, in both SW and EWW. For the rest of compounds, 
although it was not strictly necessary to correct the SPE losses, the use of ILIS slightly improved 
their extraction process efficiency but were mostly needed for matrix effects correction, as 
discussed below. The only exception was gabapentin, which low recoveries could not be 
corrected by any of the available ILIS due to its singular physico-chemical characteristics. 
 
3.4. Matrix effect study 
Matrix effect is one of the main factors affecting accuracy in LC–MS/MS methods. 
Matrix effects are due to the presence of coeluting matrix compounds that affect analyte 
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ionization leading to notable errors in quantification, unless adequately corrected or minimized. 
Matrix effects correction is complicated in environmental analysis, where matrix-matched 
calibration approach is not easy to be applied. The use of ILIS is surely the most suitable way 
although difficult to apply in multi-residue methods where a high number of ILIS would be 
required for a reliable correction. In this work, a detailed study of matrix effects was made in a 
notable number of water samples. To this aim, 10 different samples were chosen (five SW and 
five EWW) and the use of several ILIS was evaluated. 
The water extracts obtained after SPE were spiked at 50 μg/L for each individual 
compound, and the ILIS mix at 25 μg/L was also added. For each compound, the ratio between 
its response in the water extract and the response of the standard in solvent at the same 
concentration (i.e. 50 μg/L) was taken as matrix effect (ME) [25]. 
As expected, matrix effects in EWW were notably higher than in SW (Fig. 3) Signal 
suppression was observed for most PPCPs, although six of them showed ionization 
enhancement in both matrices (gabapentin, carbamapezine, benzophenone, benzophenone-1, 
valsartan and benzophenone-3). Only two compounds (benzophenone-4 and irbesartan) did not 
require correction in any of the samples tested. Consequently, matrix effect correction was 
necessary for the wide majority of PPCPs to obtain satisfactory results. In this work, the use of 
five ILIS was evaluated. As expected, when the analyte ILIS was available, the correction was 
highly satisfactory (i.e. ethylparaben, benzophenone-3, valsartan, diclofenac and ibuprofen) in 
all the water samples tested. For the remaining compounds, the selection of ILIS was based on 
the similarity in their chemical structure with the analytes under study. Thus, ethylparaben-
d4 was used to correct the paraben compounds and benzophenone-3-d5 was used for 
benzophenones ionized in positive mode. However, for the rest of analytes the selection of an 
analogue ILIS was more problematic. The best approach seemed to be the use of an ILIS with 
close retention time. For instance, furosemide was satisfactory corrected by ethylparaben-d4 in 
SW (Fig. 3a); this ILIS was also able to compensate the ionization suppression suffered by this 
compound in EWW (Fig. 3b). In the case of clofibric acid, two different ILIS, both ionized under 
negative mode (ethylparaben-d4 and diclofenac-d4) could be selected. In SW, matrix effects 
correction was more satisfactory with ethylparaben-d4 but it led to undesirable enhancement 
when used in EWW (data not shown). On the contrary, the use of diclofenac-d4 compensated 
matrix effects from 50% up to around 100%, so this ILIS was chosen in EWW. Similar situation 
was observed for carbamazepine and benzophenone-1, where benzophenone-3-d5 was able to 
correct matrix effects for both compounds in SW, whilst valsartan-d8 was found to be more 
suitable for their quantification in EWW. 
These examples illustrate that matrix effects are both compound- and matrix-dependent 
and that their correction is always complicated when the analyte ILIS is unavailable. The use of 
the own analyte ILIS is surely the best option for satisfactory correction in all sample types, but 
this assumption would need to be supported by experimental data as some labelled compounds 
(e.g. high degree of deuterated isotopes) can have different physico-chemical behavior than the 
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analyte [26]. In multi-residue methods, it uses to be unpractical to correct each compound with 
its own ILIS due to the high cost and the low commercial availability of ILIS reference standards. 
In these cases, the use of a few ILIS to compensate matrix effects for all compounds may be an 
alternative in the environmental field, although the satisfactory correction for all samples 
analyzed cannot be ensured. The choice of an appropriate internal standard is crucial in terms 
of compensation for matrix effects [27-29], although it seems insufficient to test it in just one 
given sample, due to the large variability in environmental waters and wastewaters. Thus, the 
study of matrix effects should be made in a notable number of samples trying to cover different 
situations and sample matrix compositions. 
 
(a) 
 
 
(b) 
 
 
Fig. 3. Average matrix effects (ME) for (a) five different surface water samples and (b) five 
different effluent wastewater samples, before and after correction with ILIS. Ethylparaben-d4: 
used to correct for ethylparaben, methylparaben, benzophenone-2, furosemide, propylparaben, 
clofibric acid*, butylparaben. Benzophenone-3-d5: used for benzophenone-3, carbamazepine**, 
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benzophenone-1**, benzophenone. Valsartan-d8: used for valsartan. Diclofenac-d4: used for 
diclofenac. Ibuprofen-d3: used for ibuprofen. * Correction made with diclofenac-d4 in EWW 
analysis.** Correction made with valsartan-d8 in EWW analysis. 
 
3.5. Method validation 
The method linearity was studied in the range 1–100 μg/L (these values corresponded 
to 0.01–1 μg/L in the water samples, taking into account the 100-fold pre-concentration factor 
applied along the sample procedure). Calibration curves showed satisfactory correlation 
coefficients (greater than 0.99) and residuals were lower 30% for all compounds. 
For validation purposes, each of the 10 water samples tested (five SW and five EWW 
samples) was spiked at two concentration levels. Experiments were performed in duplicate. In 
order to evaluate simultaneously the SPE recovery (RE) and the matrix effect (ME), the overall 
process efficiency (PE) was determined. Thus, the ratio between the responses obtained for 
samples spiked before SPE and the response of the standard in solvent was determined [25] in 
the method validation. 
“Blank” samples, spiked only with the ILIS mix, were also processed to subtract the 
responses of the target compounds that were present in the samples used for validation. PE 
experimental values, after correction with ILIS, for the five SW samples and the five EWW 
samples tested are shown inTable 2 and Table 3. ILIS correction was performed on the basis 
on the results obtained in the previous sections. 
The method was tested at two concentration levels (0.05 and 0.5 μg/L) in SW. At the 
lowest concentration, ibuprofen could not be validated due to the poor sensitivity. A few 
compounds could not be validated in all the SW samples tested due to the high analyte 
concentration found in some of the “blank” SW samples used in the validation (e.g. 
methylparaben, furosemide, propylparaben). 
Recoveries in SW (calculated as PE) were satisfactory (between 70% and 120%) for 
most of the compounds at the two spiking levels. Only benzophenone-4 and irbesartan were 
quantified without ILIS. Among the remaining compounds, five of them were corrected with their 
own ILIS, and the rest using an “analogue” ILIS. The use of analogue ILIS was, in general, 
satisfactory, but could not be always assured appropriate correction in all SW tested. For 
example, when carbamazepine was corrected with benzophenone-3-d5, satisfactory recoveries 
were obtained except for two of the SW samples. Recoveries significantly above 100% were 
obtained for benzophenone-1 without ILIS correction at both spiking levels (data not shown), 
which was in agreement with the signal enhancement observed in the matrix effect study. The 
use of benzophene-3-d5 as ILIS could not efficiently correct matrix effects, especially at the 
lowest level. 
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It is important to remark that, in a few cases, recoveries varied significantly from one 
sample to another (e.g. for furosemide, individual recoveries were in the range 68–126% at the 
highest level assayed). This situation was only observed when an analogue ILIS was used 
because the composition of aqueous samples is never the same, and unexpected matrix effects 
might occur. 
Regarding EWW, the method was also tested in five different samples at two 
fortification levels each (0.1 and 0.5 μg/L). All analytes were quantified using ILIS with the 
exception of benzophenone-4 and irbesartan, which presented acceptable recoveries without 
correction (see Table 3). A few compounds could not be validated in all the five samples, due to 
the high concentrations found in the “blank”, especially in one of the samples (named as EWW 
2). Recoveries were mostly satisfactory at the two levels assayed. A few compounds showed 
values higher than 120% in some of the EWW tested when the own analyte ILIS was 
unavailable (e.g. methylparaben, carbamazepine, benzophenone-1, butylparaben), illustrating 
that matrix effects for a sample type (e.g. effluent wastewater) do not remain constant along 
time and for all the samples analyzed, and can suffer notable variations. Therefore, a 
satisfactory correction could not be ensured for all the samples analyzed when using analogues 
ILIS, even though the method was tested in a notable number of water samples. 
A particular case was benzophenone, as this compound presented poor extraction 
efficiency (RE value around 50%) and remarkable signal enhancement (ME around 250%), 
leading to a PE value near 120%. Thus, the term “process efficiency” (PE) in this particular 
analyte might give a biased overall view of the method reliability. 
Instrumental LODs are shown in Table 1. They ranged from 0.3 to 10.6 pg, with the 
exception of ibuprofen. For this compound LOD was significantly higher than for the rest of 
analytes. The reason was its poor fragmentation, and that only a low sensitive transition could 
be monitored, hampering its confirmation. 
Concerning LOQs, they ranged from 0.2 to 9 ng/L for SW, and were around 10-fold 
higher than for the rest of analytes. The reason was its poor fragmentation, and that only a low 
sensitive transition could be monitored, hampering its confirmation. 
 
3.6. Application to environmental and waste water samples 
The method developed in this paper was applied to investigate the presence of 17 
PPCPs in different types of water: reservoir water (Colombia), and SW and EWW (Spain). 
In every sequence of analysis, the calibration curve was injected twice, at the beginning 
and the end of the sample batch. Moreover, quality control samples (QCs) were included in 
every sample sequence. QCs consisted on SW, EWW or reservoir water spiked at 0.5 μg/L. 
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They were prepared randomly selecting one of the water samples analyzed within the batch, 
and were analyzed following the same analytical procedure than samples. QC recoveries in the 
range 60–120% were considered as satisfactory (Tables 4 and Table 5).  
Confirmation of positive findings was carried out by calculating the peak area ratios 
between the quantification (Q) and confirmation (q1 and q2) transitions. The finding was 
considered as true positive when the experimental ion-ratio was within the tolerance range [30], 
and the retention time in the sample within ± 2.5% the retention time, when compared with a 
reference standard. 
A great variety of PPCPs were detected in a wide range of concentrations in samples 
from Spain (Table 4). In SW, 14 out of 17 PPCPs were detected at least once. Among them, 
irbesartan, benzophenone, benzophenone-3, methylparaben and propylparaben were 
quantified in all SW samples. On the contrary, clofibric acid, benzophenone-2 and butylparaben 
were not detected in any of the samples. The highest concentrations found were for valsartan 
(up to 6.3 μg/L). These results are in fairly good agreement with data reported by other authors. 
For instance, in a study carried out by Kasprzyk-Hordern et al. [31], the pharmaceuticals 
ibuprofen, diclofenac, gabapentin, furosemide and valsartan were also frequently found in SW 
samples from United Kingdom and their concentration levels were similar to those found in our 
study. Regarding PCPs, in other works highest concentrations were found for methylparaben 
and benzophenone-4 [10,31], which is in accordance with the present study. The presence of 
pharmaceuticals in “Albufera de Valencia” lake has been previously reported in literature [32], 
concretely carbamazepine (2.2–31 ng/L), ibuprofen (n.d.−3913 ng/L), clofibric acid 
(n.d.−71.4 ng/L) and diclofenac (n.d. −260.9 ng/L), among other compounds. These data are in 
the line of the present work, where carbamazepine (12 ng/L) and ibuprofen (<LOQ) were also 
found in the same area. The most polluted source was Jucar river (in Valencia) where 13 out of 
17 targeted PPCPs were detected, the majority of them at the highest concentration levels 
found in this work. 
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Regarding EWW, 10 of the target PPCPs were detected in all the samples 
(benzophenone, benzophenone-3, benzophenone-4, methylparaben, propylparaben valsartan, 
irbesartan, diclofenac, carbamazepine and furosemide). On the contrary, four compounds were 
not detected in any EWW sample: benzophenone-1, benzophenone-2, ethylparaben and 
butylparaben, which was in general agreement with data obtained in SW (benzophenone-1 and 
ethylparaben were found in only one and two surface waters, respectively). The highest levels 
were found for benzophenone-4 and valsartan, which were in the range 0.14–2 and 0.07–
5.9 μg/L, respectively. Valsartan was by far the compound present at higher levels in both SW 
and EWW samples. As expected, concentrations in EWW were usually higher than in SW. In 
agreement with other studies [10] and [31], preservatives were found at very low levels. This 
was also observed for benzophenone-1, benzophene-2 and benzophenone-3, whilst 
benzophenone-4 was one of the compounds found at higher concentrations. 
For gabapentin, due to its low recovery, only qualitative data were obtained. This 
compound was detected in four SW and in all EWW samples analyzed. It was confirmed by the 
presence of chromatographic peak at the three SRM transitions acquired for this compound. 
In relation to reservoir water from Colombia, both water sources showed less 
contamination by PPCPs than surface water from Spain. In fact, there were no evidences on the 
presence of gabapentin, ibuprofen, diclofenac, clofibric acid, valsartan, irbesartan, 
carbamazepine, furosemide and benzophenone-2 in any reservoir. A summary of the results 
obtained is shown in Table 5. On the contrary, the occurrence of parabens and two 
benzophenones was highly relevant in both reservoirs. In reservoir 1, methylparaben and 
propylparaben were present in all samples in a wide range of concentrations. These 
compounds were also found in most of the samples of the reservoir 2 (93% of positive 
samples). This is in accordance with previous studies where methylparaben was the 
preservative most frequently detected in river waters from the United Kingdom [31]. 
Ethylparaben was found in around 70% of samples from reservoir 1 and in all samples from 
reservoir 2, although at very low levels, commonly below 10 ng/L. Benzophenone and 
benzophenone-3 were detected in both reservoirs in a notable number of samples. On the 
contrary, benzophenone-1 and benzophenone-2 were only detected in the reservoir 1 in just 
one sample. 
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Recoveries for the Quality Control samples (QCs) included in every sequence of 
analysis were, in general, satisfactory, within a range of 60–120% (see Table 4 and Table 5). 
Only a few exceptions were observed in EWW and in the reservoir water samples. In all these 
cases, QCs recoveries were higher than 120% and corresponded to analytes that were 
corrected with an analogue ILIS. A correction factor was applied when the compound was 
detected and quantified in the samples (five out of six cases). 
As an illustrative example, Fig. 4 shows a positive finding of methylparaben, 
propylparaben, benzophenone and benzophenone-3 in one of the water samples collected at 
reservoir 2. From the data obtained on PCPs in the water from reservoirs, we did not observe 
specific trends in the concentrations of these compounds at the different depths considered in 
the water column. 
 
a b c d 
 
 
 
None of the target pharmaceuticals was detected in the reservoir waters from Colombia. 
This was unexpected, especially for diclofenac and ibuprofen, which seem to be widely 
consumed in this country. The reason might be found in the high dilution taking place due to the 
large capacity of these reservoirs. 
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Fig. 4. UHPLC-MS/MS chromatograms for selected analytes for a reservoir water sample.  
Methylparaben (141 ng/L), propylparaben (142 ng/L), benzophenone (7 g/L), benzophenone-3 
(6 ng/L). 
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The influence of human activities in areas near the Colombian reservoirs seems clear in 
the case of PCPs (for example, reservoir 1 is used as a recreation place and it is surrounded by 
residences), but more research and data would be required to understand the fate and behavior 
of pharmaceuticals on this aquatic environment. 
The method developed will be implemented in the laboratory of GDCON, University of 
Antioquia, from 2012. Thus, it is expected that more data will be available on PPCPs in the 
aquatic environment of this area in the near future. 
 
4. Conclusions 
In this paper a multi-residue method for the simultaneous quantification and 
confirmation of 17 emerging contaminants, including widely used pharmaceuticals and personal 
care products, has been developed and applied to surface water samples and effluent 
wastewater from Spain and Colombia. 
The method has been evaluated and validated in a total of 10 water samples (five 
surface waters and five effluent wastewaters). This number of samples, higher than usual in 
most method validations reported for PPCPs, was chosen in order to have a wider overview of 
the method performance in different water samples. The matrix effects study performed in this 
work shows severe signal suppression/enhancement, especially in some of the EWW tested. 
The correction with analyte ILIS was satisfactory in all sample types. The use of analogues ILIS 
was rather satisfactory, although it could not ensure appropriate correction in all the 
analyte/water samples combinations, as matrix effects are both compound and matrix 
dependent. As well known, the composition of water samples is never the same and notable 
changes can occur along the time and as a function of their origin. As a consequence, matrix 
effects that commonly affect LC–MS/MS methods can be rather different from one sample to 
other. Thus, the selection of appropriate analogue ILIS, when the analyte ILIS is not available, is 
controversial and should be only made after a careful study on matrix effects in a considerable 
number of water samples of different types and origin. 
The results obtained in this work after the application of the method to 73 water 
samples (surface: rivers, lakes and reservoirs, and effluent wastewater) showed the wide 
majority of the target analytes were present in the samples analyzed. The importance of 
including personal care products, which have received less attention than pharmaceuticals 
during the last years, is evidenced by the widespread occurrence of these compounds in the 
samples under study. To the best of our knowledge, the presence and distribution of PPCPs in 
Colombia have not been reported, and this is the first publication providing data on PPCPs in 
this country. 
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